Cargando…

Comparison of qualitative and quantitative imaging characteristics of [(11)C]PiB and [(18)F]flutemetamol in normal control and Alzheimer's subjects

INTRODUCTION: Neuritic amyloid plaques and neurofibrillary tangles, the hallmark pathologic lesions of Alzheimer's disease, are thought to develop before the symptoms of brain failure are clinically detectable. Imaging methods capable of detecting the presence of neuritic amyloid plaques should...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mountz, James M., Laymon, Charles M., Cohen, Ann D., Zhang, Zheng, Price, Julie C., Boudhar, Sanaa, McDade, Eric, Aizenstein, Howard J., Klunk, William E., Mathis, Chester A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633837/ https://www.ncbi.nlm.nih.gov/pubmed/26640770 http://dx.doi.org/10.1016/j.nicl.2015.10.007

Ejemplares similares

Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
por: Ikonomovic, Milos D., et al.
Publicado: (2020)

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
por: Minhas, Davneet S., et al.
Publicado: (2018)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging
por: Laymon, Charles M., et al.
Publicado: (2021)

[(18)F]FDG, [(11)C]PiB, and [(18)F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline
por: Okonkwo, David O., et al.
Publicado: (2019)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities
por: Goodheart, A.E., et al.
Publicado: (2015)

Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging
por: Yan, Qi, et al.
Publicado: (2018)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
por: Hatashita, Shizuo, et al.
Publicado: (2019)

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
por: Ikonomovic, Milos D., et al.
Publicado: (2016)

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
por: Ikonomovic, Milos D., et al.
Publicado: (2008)

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
por: Laforce, Robert, et al.
Publicado: (2014)

Comparison of [(18)F]Flutemetamol and [(11)C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
por: Lowe, Val J., et al.
Publicado: (2017)

Can (11)C-PiB-PET Relative Delivery R(1) or (11)C-PiB-PET Perfusion Replace (18)F-FDG-PET in the Assessment of Brain Neurodegeneration?
por: Oliveira, Francisco P.M., et al.
Publicado: (2018)

Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
por: Luckett, Emma S., et al.
Publicado: (2023)

Image reconstruction methods affect software-aided assessment of pathologies of [(18)F]flutemetamol and [(18)F]FDG brain-PET examinations in patients with neurodegenerative diseases
por: Lindström, Elin, et al.
Publicado: (2020)

Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease
por: Yan, Lirong, et al.
Publicado: (2017)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive decline
por: Mizuno, Akiko, et al.
Publicado: (2023)

Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
por: Seo, Sang Won, et al.
Publicado: (2016)

Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
por: Zwan, Marissa D., et al.
Publicado: (2017)

Clinical Profile of PiB-Positive Corticobasal Syndrome
por: Burrell, James R., et al.
Publicado: (2013)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects
por: Glodzik, Lidia, et al.
Publicado: (2016)

Amyloid-Targeting PET Tracer [(18)F]Flutemetamol Accumulates in Atherosclerotic Plaques
por: Hellberg, Sanna, et al.
Publicado: (2019)

Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden
por: Kiddle, Steven John, et al.
Publicado: (2012)

Quantitative Analysis of PiB-PET with FreeSurfer ROIs
por: Su, Yi, et al.
Publicado: (2013)

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
por: Oliveira, Francisco, et al.
Publicado: (2018)

Assessing Amyloid Pathology in Cognitively Normal Subjects Using (18)F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
por: Collij, Lyduine E., et al.
Publicado: (2019)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Characterization and Evaluation of Transgenic Rice Pyramided with the Pi Genes Pib, Pi25 and Pi54
por: Peng, Meifang, et al.
Publicado: (2021)

Head-to-head comparison of (11)C-PiB and (18)F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients
por: Byun, Byung Hyun, et al.
Publicado: (2017)

Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer’s disease, subjects with amnestic mild cognitive impairment and healthy volunteers
por: Miki, Takami, et al.
Publicado: (2017)

Early-phase (18)F-FP-CIT and (18)F-flutemetamol PET were significantly correlated
por: An, Young-Sil, et al.
Publicado: (2021)

MR-Less Surface-Based Amyloid Assessment Based on (11)C PiB PET
por: Zhou, Luping, et al.
Publicado: (2014)

Noninvasive Measurement of [(11)C]PiB Distribution Volume Using Integrated PET/MRI
por: Okazawa, Hidehiko, et al.
Publicado: (2020)

Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [(11)C]PiB
por: Heeman, Fiona, et al.
Publicado: (2021)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

The correlation of neuropsychological evaluation with (11)C-PiB and (18)F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease
por: Park, Su Yeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dacrt5nghc1cusukpk5pejr6n